Cisatracurium Other names: Cisatracurium besilate

Chemical formula: C₆₅H₈₂N₂O₁₈S₂  Molecular mass: 929.16 g/mol  PubChem compound: 62886

Therapeutic indications

Cisatracurium is indicated for:

Tracheal Intubation

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Intubation of respiratory tract
Induction of neuromuscular blockade

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Mechanical ventilation

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Cisatracurium can be used as an adjunct to general anaesthesia, or sedation in the Intensive Care Unit (ICU) to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cisatracurium is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Hypersensitivity to cisatracurium, atracurium, or benzenesulfonic acid

at least one of
Allergy to cisatracurium
Atracurium allergy
BENZENESULFONIC ACID

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.